SCIENTIFIC BACKGROUND

ADRA2B, CACNB4, CASR, CERS1, CLCN2, CNTN2, CSTB, EFHC1, EPM2A, GABRA1, GABRD, GOSR2, KCNC1, KCNMA1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, PRICKLE2, SCARB2, SLC6A1, TBC1D24

  • Epilepsy with myoclonic-atonic seizures (MAE) (SLC6A1, AD)
  • Familial infantile myoclonic epilepsy (FIME) (TBC1D24, AR)
  • Familial myoclonic epilepsy of adulthood 2 (ADRA2B, AD)
  • Familial myoclonic epilepsy of adulthood 5 (CNTN2, AR)
  • Generalized epilepsy with paroxysmal dyskinesia (GEPD) (KCNMA1, AD)
  • Idiopathic generalized epilepsy type 8 (CASR, AD)
  • Juvenile myoclonic epilepsy type 1 (EJM1) (EFHC1, AD)
  • Juvenile myoclonic epilepsy type 5 (EJM5) (GABRA1, AD)
  • Juvenile myoclonic epilepsy type 6 (EJM6) (CACNB4, AD)
  • Juvenile myoclonic epilepsy type 7 (EJM7) (GABRD, AD)
  • Juvenile myoclonic epilepsy type 8 (EJM8) (CLCN2, AD)
  • Progressive myoclonic epilepsy type 10 (PME10) (PRDM8, AR)
  • Progressive myoclonic epilepsy type 1A (PME1A) (Unverricht and Lundborg) (CSTB, AR)
  • Progressive myoclonic epilepsy type 1B (PME1B) (Unverricht and Lundborg) (PRICKLE1, AR)
  • Progressive myoclonic epilepsy type 2A (PME2A; Lafora) (EPM2A, AR)
  • Progressive myoclonic epilepsy type 2B (PME2B; Lafora) (NHLRC1, AR)
  • Progressive myoclonic epilepsy type 3 with or without intracellular inclusions (PME3) (KCTD7, AR)
  • Progressive myoclonic epilepsy type 4 with or without renal failure (PME4) (SCARB2, AR)
  • Progressive myoclonic epilepsy type 5 (PME5) (PRICKLE2, AD)
  • Progressive myoclonic epilepsy type 6 (PME6) (GOSR2, AR)
  • Progressive myoclonic epilepsy type 7 (PME7) (KCNC1, AD)
  • Progressive myoclonic epilepsy type 8 (PME8) (CERS1, AR)
  • Progressive myoclonic epilepsy type 9 (PME9) (LMNB2, AR)

 

Disorders are inherited in an autosomal dominant (AD) or autosomal recessive (AR) pattern. Genes in bold are core genes.

 

Epilepsy, juvenile myoclonic

Genes: CACNB4, CASR, CLCN2, EFHC1, GABRA1, GABRD, KCNMA1, SLC6A1, TBC1D24

 

Epilepsy, progressive myoclonic

Genes: CERS1, CSTB, EPM2A, GOSR2, KCNC1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, SCARB2

 

For detailed information on epilepsies and diagnostics, please visit our overview page EPILEPSY.

GENES

ADRA2B, CACNB4, CASR, CERS1, CLCN2, CNTN2, CSTB, EFHC1, EPM2A, GABRA1, GABRD, GOSR2, KCNC1, KCNMA1, KCTD7, LMNB2, NHLRC1, PRDM8, PRICKLE1, PRICKLE2, SCARB2, SLC6A1, TBC1D24

ASSOCIATED TESTS

How to order

LATEST ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more